Results 181 to 190 of about 31,541 (206)

Lopinavir/ritonavir

Reactions Weekly, 2002
openaire   +2 more sources

Switch to a raltegravir-based regimen versus continuation of a lopinavir-ritonavir-based regimen in stable HIV-infected patients with suppressed viraemia (SWITCHMRK 1 and 2): two multicentre, double-blind, randomised controlled trials

Lancet, The, 2010
Joseph J Eron, Benjamin Young, Edwin Dejesus   +2 more
exaly  

Lopinavir

2017
openaire   +1 more source

Modified pullulan nanoparticles for oral delivery of lopinavir: Formulation and pharmacokinetic evaluation

Carbohydrate Polymers, 2014
Punna Rao Ravi, Rahul Vats
exaly  

Lopinavir.

2011
openaire   +1 more source

Population pharmacokinetics of lopinavir in combination with rifampicin-based antitubercular treatment in HIV-infected South African children

European Journal of Clinical Pharmacology, 2010
Helen Mcilleron, Gary Maartens, Ulrika S H Simonsson   +2 more
exaly  

Lopinavir

2016
openaire   +1 more source

Lopinavir

2007
openaire   +1 more source

Efficacy and safety of darunavir-ritonavir compared with that of lopinavir-ritonavir at 48 weeks in treatment-experienced, HIV-infected patients in TITAN: a randomised controlled phase III trial

Lancet, The, 2007
JOSÉ Valdez Madruga, Daniel Berger, Fredy Suter   +2 more
exaly  

Lopinavir/ritonavir

Reactions Weekly, 2007
openaire   +2 more sources